The Subject Expert Committee (SEC), which advises India’s central drug regulatory authority on new drugs and clinical trials, has recommended that Biological E's COVID-19 vaccine
BioMarin to Acquire Inozyme Pharma for USD 270 MillionBioMarin Pharmaceutical, Inc. has publicly disclosed a definitive agreement to acquire Inozyme Pharma, Inc in an all-cash transaction of nearly USD 270 million...
74th Indian Pharmaceutical Congress 2025 Opens RegistrationsThe Indian Pharmaceutical Congress, 2025 (IPC), which is organized by the Association of Pharmaceutical Teachers of India (APTI), has opened its registration...
Sun Pharmaceutical Industries Limited reported that the U.S. Food and Drug Administration (FDA) has now approved premarket approval application (PMA) for the new, next generation BLU-U PDT Illuminator.
Scientists at the National Institutes of Health (NIH) have found that alterations in the structure and cell composition of breast connective tissue, or stroma, are associated with a heightened risk for aggressive breast cancer in women with benign...
Roche has announced FDA approval for the Ventana MET (SP44) RxDx Assay, emphasizing their first companion diagnostic designed to identify MET protein appearance in patients.
US President Donald Trump’s new price range for Rx drugs with other developed countries might not affect the generic companies in India.
DoP Invites Fresh Applications Under PLI Scheme for Bulk DrugsThe Department of Pharmaceuticals (DoP) has sought new applications under the Production Linked Incentive (PLI) scheme for bulk drugs, for products that have not been applied for or...
Fortis Partners with Teleflex for South Asia UroLift TrainingFortis Hospitals, Bengaluru, has signed a strategic partnership with Teleflex Incorporated, a world-renowned leader in medical technologies, to set up the UroLift Centre of Education...
India is growing efforts to extend pharmaceutical trade with Southeast Asia as the Pharmaceuticals Export Promotion Council of India.
, CDSCO.jpg)
